Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Megan Crumbaker

Rapid Modulation of PSMA Expression by Androgen Deprivation: Serial 68Ga PSMA-11 PET in Men With Hormone Sensitive and Castrate Resistant Prostate Cancer Commencing Androgen Blockade.

Journal of Nuclear Medicine

English

Related publications

Impact of Long-Term Androgen Deprivation Therapy on PSMA Ligand PET/CT in Patients With Castration-Sensitive Prostate Cancer

European Journal of Nuclear Medicine and Molecular Imaging

English

Meta-Analysis of 68Ga-Psma-11 PET Accuracy for the Detection of Prostate Cancer Validated by Histopathology

Journal of Nuclear Medicine

English

68Ga PSMA-11 PET With CT Urography Protocol in the Initial Staging and Biochemical Relapse of Prostate Cancer

Cancer Imaging

Nuclear Medicine

Radiology

Ultrasound Technology

English

Immunohistochemical Validation of PSMA-expression Measured by 68 Ga-Psma PET/CT in Primary Prostate Cancer

Journal of Nuclear Medicine

English

Comparison of 68Ga-Psma-11 PET/CT With 11c-Acetate PET/CT in Re-Staging of Prostate Cancer Relapse

Scientific Reports

Multidisciplinary

2020

English

Comparison of [18F]DCFPyL and [68Ga]Ga-Psma-Hbed-Cc for PSMA-PET Imaging in Patients With Relapsed Prostate Cancer

Molecular Imaging and Biology

English

(OA35) Impact of Staging 68Ga-Psma-11 Pet Scans on Radiation Treatment Plans in Patients With Prostate Cancer

International Journal of Radiation Oncology Biology Physics

English

Risk of the "Androgen Deprivation Syndrome" in Men Receiving Androgen Deprivation for Prostate Cancer

Archives of Internal Medicine

2006

English

Correction To: Randomized Prospective Phase III Trial of 68Ga-Psma-11 PET/CT Molecular Imaging for Prostate Cancer Salvage Radiotherapy Planning [PSMA-SRT]

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Megan Crumbaker

Rapid Modulation of PSMA Expression by Androgen Deprivation: Serial 68Ga PSMA-11 PET in Men With Hormone Sensitive and Castrate Resistant Prostate Cancer Commencing Androgen Blockade.

Related publications

Impact of Long-Term Androgen Deprivation Therapy on PSMA Ligand PET/CT in Patients With Castration-Sensitive Prostate Cancer

Meta-Analysis of 68Ga-Psma-11 PET Accuracy for the Detection of Prostate Cancer Validated by Histopathology

68Ga PSMA-11 PET With CT Urography Protocol in the Initial Staging and Biochemical Relapse of Prostate Cancer

Immunohistochemical Validation of PSMA-expression Measured by 68 Ga-Psma PET/CT in Primary Prostate Cancer

Comparison of 68Ga-Psma-11 PET/CT With 11c-Acetate PET/CT in Re-Staging of Prostate Cancer Relapse

Comparison of [18F]DCFPyL and [68Ga]Ga-Psma-Hbed-Cc for PSMA-PET Imaging in Patients With Relapsed Prostate Cancer

(OA35) Impact of Staging 68Ga-Psma-11 Pet Scans on Radiation Treatment Plans in Patients With Prostate Cancer

Risk of the "Androgen Deprivation Syndrome" in Men Receiving Androgen Deprivation for Prostate Cancer

Correction To: Randomized Prospective Phase III Trial of 68Ga-Psma-11 PET/CT Molecular Imaging for Prostate Cancer Salvage Radiotherapy Planning [PSMA-SRT]